Fragment-based approaches and the prospect of fragmented prodrugs.
Antonow
Dyeison
D
D015195:Drug Design; D055808:Drug Discovery; D006801:Humans; D058990:Molecular Targeted Therapy; D057285:Precision Medicine; D011355:Prodrugs / Q000378:metabolism
D011355:Prodrugs